aphtheal 5% w/w oromucosal paste
mylan ire healthcare limited - amlexanox - oromucosal paste - 5 percent weight/weight - other agents for local oral treatment; amlexanox
orosoothe 0.15% w/v oromucosal spray
phoenix labs - benzydamine hydrochloride - oromucosal spray - 0.15 percent weight/volume - benzydamine
difflam spray, 0.15% w/v, oromucosal spray
mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - benzydamine hydrochloride - oromucosal spray - benzydamine hydrochloride 0.15 % (w/v) - antiinflammatory and antirheumatic products
epistatus 10 mg oromucosal solution
veriton pharma limited - midazolam - oromucosal solution - 10 milligram(s) - midazolam
epistatus 10 mg oromucosal solution
serb s.a., - midazolam - oromucosal solution - 10 milligram(s) - midazolam
difflam spray, 0.15% w/v, oromucosal spray
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - oromucosal spray - benzydamine hydrochloride 0.15 % (w/v) - antiinflammatory and antirheumatic products
epistatus 2.5 mg oromucosal solution
serb s.a., - midazolam - oromucosal solution - midazolam
epistatus 5 mg oromucosal solution
serb s.a., - midazolam - oromucosal solution - midazolam
epistatus 7.5 mg oromucosal solution
serb s.a., - midazolam - oromucosal solution - midazolam
venofer iron 100mg/5ml (as iron(iii) hydroxide sucrose complex) injection
seqirus pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).